TrialThe Journal of infectious diseases2026

Safety and Immunogenicity of a Severe Acute Respiratory Syndrome Coronavirus 2 Spike Subunit Vaccine Stabilized in the Prefusion Conformation by a Second-Generation Molecular Clamp and Evaluated in Adults Aged 18-55 Years: A Randomized, Double-Blind, Active Comparator, Phase I Trial.

Keith J Chappell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.